Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ulcerative Colitis
|
827 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.050 | 1.000 | 5 | 2008 | 2014 | |||||
Asthma
|
1536 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.060 | 1.000 | 6 | 2010 | 2018 | |||||
Bronchiolitis
|
32 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.020 | 1.000 | 2 | 2010 | 2018 | |||||
Childhood asthma
|
317 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.020 | 1.000 | 2 | 2010 | 2018 | |||||
Acute GVH disease
|
49 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Autoimmune Diseases
|
428 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Malignant neoplasm of stomach
|
615 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.100 | 0.857 | 14 | 2012 | 2018 | |||||
Stomach Carcinoma
|
652 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.100 | 0.857 | 14 | 2012 | 2018 | |||||
Breast Carcinoma
|
2793 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Duodenal Diseases
|
2 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Malignant neoplasm of breast
|
3417 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Mucosal atrophy
|
5 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Peptic Ulcer
|
25 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Tuberculosis
|
328 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.050 | 0.600 | 5 | 2013 | 2017 | |||||
Periodontitis
|
116 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.030 | 1.000 | 3 | 2013 | 2017 | |||||
Tuberculosis, Pulmonary
|
171 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.020 | 1.000 | 2 | 2013 | 2016 | |||||
Bladder Neoplasm
|
281 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Carcinoma of bladder
|
309 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Cardiomyopathy, Familial Idiopathic
|
243 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.010 | 1 | 2013 | 2013 | ||||||
Impaired cognition
|
348 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Malignant neoplasm of urinary bladder
|
316 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Neoplasms
|
1644 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Parkinson Disease
|
990 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Periodontal Diseases
|
22 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Primary antiphospholipid syndrome
|
1 | 0.514 | 0.760 | 6 | 52186235 | upstream gene variant | G/A | snv | 0.28 | 0.010 | 1.000 | 1 | 2013 | 2013 |